comparemela.com

Latest Breaking News On - Allegis capital - Page 10 : comparemela.com

New report indicates potential investing gap for BC s early-stage startups

New report indicates potential investing gap for BC’s early-stage startups A new analysis by Hockeystick of British Columbia’s deal activity for 2020 shows a gap in early-stage startup funding. Hockeystick’s BC Tech Report looks at how the province’s tech ecosystem fared in terms of deals and dollars, with data sourced through exclusive partnerships with organizations like the Canadian Venture Capital and Private Equity Association (CVCA). Hockeystick also compiles data from startups using its platform, as well as public data sources. In 2020, BC saw general capital support across all stages. Early-stage deals accounted for 31 percent of all deals, while Series A deals accounted for 20 percent, and late-stage deals accounted for 40 percent. Since Hockeystick’s Q2 2020 report, there has been consistent late-stage activity for the region.

HomePod | Benzinga

The home smart speaker market could be the next major hardware boom in the tech sector. The Amazon.com, Inc. (NASDAQ: AMZN) Echo got the first-mover advantage in the space, but the latest data suggests the top competitor is gaining ground. What Happened? A new survey by Loup Ventures found that the. Read More.

Healthcare Specific AI Platform Lumiata Raises Series B Funding

Healthcare Specific AI Platform Lumiata Raises Series B Funding No-code products speedily predict underwriting and actuarial factors enabling extreme risk reduction and cost savings for healthcare companies News provided by Share this article Share this article SAN MATEO, Calif., Jan. 14, 2021 /PRNewswire/  Lumiata, the healthcare-specific AI platform, announced today that it has completed $14 million in Series B funding, led by Defy.vc and AllegisNL Capital along with existing investors Lumiata CEO, Dilawar Syed Lumiata takes disparate healthcare-specific datasets and has them machine learning-ready within weeks. Once the data is analyzed using AI, Lumiata is able to identify underwriting risks, surface opportunities to reduce costs, and enable better care by providing reliable predictions to patient outcomes. Lumiata is the only AI platform able to make predictions down to the individual member level while protecting members privacy.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.